Nine-year overview of dyslipidemia management in children with heterozygous familial hypercholesterolemia: a university hospital outpatient lipid clinic project in Northwestern Greece

20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia

(2019) Ilse K. Luirink et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia

(2016) Michael M. Mendelson et al.   JOURNAL OF PEDIATRICS

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

(2015) Albert Wiegman et al.   EUROPEAN HEART JOURNAL

Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention

(2015) Giuliana Mombelli et al.   Journal of Clinical Lipidology

Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study

(2015) Marjet J.A.M. Braamskamp et al.   Journal of Clinical Lipidology

Efficacy and Safety of Ezetimibe Monotherapy in Children with Heterozygous Familial or Nonfamilial Hypercholesterolemia

(2015) D. Meeike Kusters et al.   JOURNAL OF PEDIATRICS

Prevalence of and Trends in Dyslipidemia and Blood Pressure Among US Children and Adolescents, 1999-2012

(2015) Brian K. Kit et al.   JAMA Pediatrics

Familial Hypercholesterolemia in Greek children and their families: Genotype-to-phenotype correlations and a reconsideration of LDLR mutation spectrum

(2014) Vasiliki Mollaki et al.   ATHEROSCLEROSIS

Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype–phenotype relationship, and clinical outcome

(2014) Barbara Sjouke et al.   EUROPEAN HEART JOURNAL

Endothelial Dysfunction, But Not Structural Atherosclerosis, Is Evident Early in Children With Heterozygous Familial Hypercholesterolemia

(2013) Antonios P. Vlahos et al.   PEDIATRIC CARDIOLOGY

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

(2012) Marianne Benn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Lipid Screening and Cardiovascular Health in Childhood

(2008) S. R. Daniels et al.   PEDIATRICS